Onset of Inattention and Hyperactivity in Children and Adolescents With Epilepsy 6 months After the Diagnosis
Željka Rogač1, Dejan Stevanović2, Sara Bečanović3
1Clinical Centre of Montenegro, Podgorica, Montenegro.
Insights
Pediatric epilepsy patients showed increased attention and hyperactivity symptoms 6 months after diagnosis and starting medication. These symptoms emerged even without prior ADHD diagnosis.
Area of Science:
- Neurology
- Pediatric Neurology
- Neurodevelopmental Disorders
Background:
- Attention-Deficit/Hyperactivity Disorder (ADHD) symptoms are frequently observed in epilepsy.
- The emergence of ADHD symptoms in pediatric epilepsy patients without comorbid ADHD requires further investigation.
Purpose of the Study:
- To evaluate inattention and hyperactivity symptoms in children and adolescents with newly diagnosed epilepsy over the first six months.
- To identify predictors of these symptoms in the early stages of epilepsy management.
Main Methods:
- A prospective study followed pediatric epilepsy patients for six months post-diagnosis and initiation of antiseizure medications.
- Behavioral assessments included the Nisonger Child Behavior Rating Form (NCBRF) and the Adverse Event Profile (AEP).
- Cognitive function was assessed using the Revised Wechsler Intelligence Scale for Children.
Main Results:
- A significant increase in attention difficulties and a moderate increase in hyperactivity levels were observed.
- Predictors for inattention included AEP scores, changes in non-verbal intelligence, and baseline/follow-up hyperactivity and attention levels.
- Hyperactivity was predicted by baseline hyperactivity and follow-up inattention.
Conclusions:
- Inattention and hyperactivity symptoms significantly emerged six months after epilepsy diagnosis and the commencement of antiseizure medication.
- These findings highlight the need for monitoring behavioral symptoms in pediatric epilepsy patients.
Objective:
Complete or major symptoms of ADHD are often present in epilepsy. This study evaluated inattention and hyperactivity symptoms over the first 6 months in newly diagnosed pediatric epilepsy without comorbid ADHD.
Method:
Children and adolescents with newly diagnosed epilepsy were followed for 6 months after starting antiseizure medications. The Nisonger Child Behavior Rating Form (NCBRF), Adverse Event Profile (AEP), and the Revised Wechsler Intelligence Scale for Children were used.
Results:
There was a marked increase in attention difficulties while a moderate increase in hyperactivity levels. AEP scores, changes in non-verbal aspects of intelligence, levels of hyperactivity at the follow-up, and attention at baseline were significant predictors for inattention. In contrast, only levels of hyperactivity at the baseline and inattention at the follow-up were significant predictors for hyperactivity.
Conclusion:
Significant inattention and hyperactivity levels originated 6 months after the diagnosis of epilepsy and starting antiseizure medication.
More Related Videos
10:22Interictal High Frequency Oscillations Detected with Simultaneous Magnetoencephalography and Electroencephalography as Biomarker of Pediatric Epilepsy
Published on: December 6, 2016
09:57Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization
Published on: September 20, 2024
Related Concept Videos
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Arteries of the Lower Limbs
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Seizures: Classification
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
